CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- PRER14A Other PRER14A
- 8-K/A Event Executive or director change
- 8-K Event Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Delisting notice
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy General Counsel & Secretary bought 26,667 shares
- 4 Open-market buy Director bought 6,667 shares
- 4 Open-market buy Director bought 66,667 shares
- 4 Open-market buy CSO & COO bought 46,667 shares
- 4 Open-market buy Director bought 13,332 shares
- 4 Open-market buy President & CEO bought 66,667 shares
- 4 Open-market buy 10% owner bought 133,333 shares
Page 18 of 78 · 1,549 filings